InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: Number sleven post# 390113

Thursday, 10/06/2022 1:04:01 PM

Thursday, October 06, 2022 1:04:01 PM

Post# of 426487
sleven...I agree...Asking for a PA on skinny label drugs would be a good solution to the skinny label problem.

"I don't know nutthin"...i.e.about the reason for which my skinny label drug is being prescribed...is a dodge now commonly being used falsely by generic companies and insurance companies in order to infringe on patented indications without penalties... and to reap unwarranted profits at the expense of "robust labels"

During the ninth circuit trial, judge Du warned Hikma against using Vascepa for the CVD indication...but the warning went unheeded just as for so many other "skinny label" drugs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News